SARS-CoV-2-ELISA-AG SARS-CoV-2 Nucleocapsid Protein Antigen Detection Kit

SARS-CoV-2-ELISA-AG kit is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigen by ELISA assay in nasopharyngeal and oropharyngeal swabs.

  1. Qualitative detection of SARS-CoV-2 nucleocapsid antigen by ELISA assay in clinical samples

  1. Target analyte: nucleocapsid (N) protein of SARS-CoV-2 coronavirus
  2. Fast and simple protocol

Pack Size, ml REF Price, €

Intended purpose SARS-CoV-2 antigen detection
Number of tests 96 tests
Technology Qualitative ELISA assay
Equipment Microplate reader for absorbance measurement at 450 and at 620–700 nm
Clinical material Nasopharyngeal and oropharyngeal swabs
Analytical specificity The potentially interfering substances do not interfere with the assay result*
Limits of detection 5 pg/ml for PBS as transport medium; 25 pg/ml for UTM® (COPAN Diagnostics Inc) as transport medium
Diagnostic specificity 99% (95% CI 95 % – 100%)*
Diagnostic sensitivity 98 % (95% CI 89% – 100%)*
Storage conditions 2–8 ºC
Transportation conditions 2–8 ºC*
Shelf life 12 months
* See the user manual for the details